Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEAK PRP for Chronic Lateral Epicondylosis
NCT03072381Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Jan 2017
- Primary completion
- Oct 2020
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of PEAK Platelet Rich Plasma in Lateral Epicondylitis (LET), sponsored by University of Wisconsin–Madison. Primary endpoint: Disabilities of the Arm, Shoulder and Hand at 52 weeks. Started Jan 2017; status: completed.
02
Drugs
PEAK Platelet Rich Plasma
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT03072381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03072381.